Well, no, we cannot agree that GAC is appropriate for some people. We simply don't know. And, that is the point of the story.
No long-term studies demonstrate that GAC for children and adolescents leads to better mental health outcomes. A recent comprehensive independent review of clinical studies commissioned by Florida (May 2022) found …
Well, no, we cannot agree that GAC is appropriate for some people. We simply don't know. And, that is the point of the story.
No long-term studies demonstrate that GAC for children and adolescents leads to better mental health outcomes. A recent comprehensive independent review of clinical studies commissioned by Florida (May 2022) found that the evidence in support of GAC was of “low” and “very low” certainty because of small sample sizes, biased samples, limited follow-up, and inconsistent outcome measures. The Florida evidence review concluded that “[d]ue to the limitations in the body of evidence, there is great uncertainty about the effects of puberty blockers, cross-sex hormones and surgeries in young people with gender dysphoria.”
Several recent European systematic reviews of evidence on GAC came to similar conclusions.
Public health authorities in the UK, Finland, and Sweden all concluded that there is insufficient
evidence to support the claim that either puberty blockers or cross-sex hormones provide mental health benefits for gender dysphoric children and adolescents. The Swedish health authority, for example, came to the stark conclusion that “the risks of puberty suppressing treatment withGnRH-analogues and gender-affirming hormonal treatment currently outweigh the possible benefits, and that the treatments should be offered only in exceptional cases.”
WPATH has been around since 1979. They are the world's foremost authority on the subject. And they strongly disagree with the Cass Report. Their Standards of Care recommendations are thoroughly grounded in science.
Part of their public statement:
"In contrast to what the Cass Review recommends, WPATH and USPATH firmly stand
by the Standards of Care for the Health of Transgender and Gender Diverse People –
version 8, which was published in 2022—and based on far more systematic reviews
that the Cass Review—in collaboration with The School of Evidence-based Practice
Center at Johns Hopkins University and considers that the (research and consensusbased) evidence is such to recommend that providing medical treatment including
puberty-blocking medication and hormone therapy is helpful and often life-saving for
young TGD people, while withholding such treatment may lead to increased gender
dysphoria and adversely affect psychological functioning. Of note, many countries
have reacted critically regarding the Cass Review, disagreeing with its unfounded
medical opinion to severely limit the use of puberty-blocking medication and
hormone therapy for TGD young people. These countries include Canada, the
Netherlands, Belgium, Germany, Austria, Switzerland, and many states in the United
States. In Germany, a new guideline on adolescent transgender care has been
drafted (in collaboration with Austria and Switzerland) and is currently under review
by 27 professional societies. As drafted, this guideline does not restrict puberty
blockers and is in broad accordance with the WPATH SOC8 recommendations in its
adolescent chapter. The Cass Review appears to be an outlier, ignoring more than
three decades of clinical experience in this area as well as existing evidence showing
the benefits of hormonal interventions on the mental health and quality of life of
You are absolutely correct, I’m not an expert and don’t claim to be. Therefore, I must rely on scientific research and explanation, of which there is a paucity in this topic.
You can help me by explaining the precise mechanistic process by which a mood disorder can be cured by permanent disfigurement of God’s (or nature’s if you prefer) physical form.
No one has any expertise in this area, because men cannot become females.
There are zoologists who specialize in certain amphibians changing sex due to population shifts - actual science.
The cryptozoologists trying to find Bigfoot and Nessy have more scientific foundation than some dude in a dress claiming male humans can become female humans. Yes, it’s perfectly logical to argue that some men prefer wearing a dress rather than jeans (tongue-in-cheek, that’s why Scotland is part of the United Kingdom and only gets recognized at anachronistic festivals). That makes them transvestites - they trade in their shorts for skirts, not their balls for ovaries.
If your balls get lopped off, there are plenty of terms that apply (gelding, eunuch, ox, etc.), none of which is “woman.”
WPATH (and you by posting their statement) are lying. Sweden, France, Denmark, Germany, England, Wales, Scotland, Netherlands, Scotland, and Belgium have all taken action to greatly restrict puberty blockers and other gender-denial care. Additionally, WPATH internal emails have just dropped proving they forbade the release of their most recent research review findings because it DID NOT SUPPORT WPATH SOC.
Well, no, we cannot agree that GAC is appropriate for some people. We simply don't know. And, that is the point of the story.
No long-term studies demonstrate that GAC for children and adolescents leads to better mental health outcomes. A recent comprehensive independent review of clinical studies commissioned by Florida (May 2022) found that the evidence in support of GAC was of “low” and “very low” certainty because of small sample sizes, biased samples, limited follow-up, and inconsistent outcome measures. The Florida evidence review concluded that “[d]ue to the limitations in the body of evidence, there is great uncertainty about the effects of puberty blockers, cross-sex hormones and surgeries in young people with gender dysphoria.”
Several recent European systematic reviews of evidence on GAC came to similar conclusions.
Public health authorities in the UK, Finland, and Sweden all concluded that there is insufficient
evidence to support the claim that either puberty blockers or cross-sex hormones provide mental health benefits for gender dysphoric children and adolescents. The Swedish health authority, for example, came to the stark conclusion that “the risks of puberty suppressing treatment withGnRH-analogues and gender-affirming hormonal treatment currently outweigh the possible benefits, and that the treatments should be offered only in exceptional cases.”
Clearly you have no expertise in this area.
WPATH has been around since 1979. They are the world's foremost authority on the subject. And they strongly disagree with the Cass Report. Their Standards of Care recommendations are thoroughly grounded in science.
Part of their public statement:
"In contrast to what the Cass Review recommends, WPATH and USPATH firmly stand
by the Standards of Care for the Health of Transgender and Gender Diverse People –
version 8, which was published in 2022—and based on far more systematic reviews
that the Cass Review—in collaboration with The School of Evidence-based Practice
Center at Johns Hopkins University and considers that the (research and consensusbased) evidence is such to recommend that providing medical treatment including
puberty-blocking medication and hormone therapy is helpful and often life-saving for
young TGD people, while withholding such treatment may lead to increased gender
dysphoria and adversely affect psychological functioning. Of note, many countries
have reacted critically regarding the Cass Review, disagreeing with its unfounded
medical opinion to severely limit the use of puberty-blocking medication and
hormone therapy for TGD young people. These countries include Canada, the
Netherlands, Belgium, Germany, Austria, Switzerland, and many states in the United
States. In Germany, a new guideline on adolescent transgender care has been
drafted (in collaboration with Austria and Switzerland) and is currently under review
by 27 professional societies. As drafted, this guideline does not restrict puberty
blockers and is in broad accordance with the WPATH SOC8 recommendations in its
adolescent chapter. The Cass Review appears to be an outlier, ignoring more than
three decades of clinical experience in this area as well as existing evidence showing
the benefits of hormonal interventions on the mental health and quality of life of
gender diverse young people (1-9)."
You are absolutely correct, I’m not an expert and don’t claim to be. Therefore, I must rely on scientific research and explanation, of which there is a paucity in this topic.
You can help me by explaining the precise mechanistic process by which a mood disorder can be cured by permanent disfigurement of God’s (or nature’s if you prefer) physical form.
No one has any expertise in this area, because men cannot become females.
There are zoologists who specialize in certain amphibians changing sex due to population shifts - actual science.
The cryptozoologists trying to find Bigfoot and Nessy have more scientific foundation than some dude in a dress claiming male humans can become female humans. Yes, it’s perfectly logical to argue that some men prefer wearing a dress rather than jeans (tongue-in-cheek, that’s why Scotland is part of the United Kingdom and only gets recognized at anachronistic festivals). That makes them transvestites - they trade in their shorts for skirts, not their balls for ovaries.
If your balls get lopped off, there are plenty of terms that apply (gelding, eunuch, ox, etc.), none of which is “woman.”
WPATH (and you by posting their statement) are lying. Sweden, France, Denmark, Germany, England, Wales, Scotland, Netherlands, Scotland, and Belgium have all taken action to greatly restrict puberty blockers and other gender-denial care. Additionally, WPATH internal emails have just dropped proving they forbade the release of their most recent research review findings because it DID NOT SUPPORT WPATH SOC.